IMAB: I-MAB - American Depositary Shares

IMAB News

• Investing 15:21 I-Mab reports 83% response rate for givastomig in gastric cancer study
• Investing 20:05 I-Mab’s givastomig shows promising results in gastric cancer study
• Investing 11:41 I-Mab stock maintains buy rating at H.C. Wainwright on strong cancer data
• Investing 10:36 I-Mab reports 71% response rate for gastric cancer drug in trial
• Investing 11:39 H.C. Wainwright reiterates buy rating on I-Mab stock ahead of key data
• Investing 11:16 I-Mab to Host Webinar to Recap New Givastomig Data, in Combination with Immunochemotherapy, Expected at ESMO GI 2025
• Investing 18:09 I-Mab at H.C. Wainwright: Strategic Shift Towards U.S. Operations
• Investing 11:05 I-Mab regains Nasdaq compliance as shares maintain $1 minimum bid
• Investing 21:06 IMAB at Jefferies Global Healthcare Conference: Promising Pipeline Developments
• Investing 11:20 I-Mab to Participate in the H.C. Wainwright HCW@Home Series
• Investing 19:11 I-Mab stock surges on Lucid Capital’s buy rating initiation
• Investing 12:22 Lucid Capital sets I-Mab stock Buy rating, $5 target on cancer drug potential
• Investing 11:16 I-Mab to Present at Jefferies Global Healthcare Conference
• Investing 11:32 I-Mab Reports First Quarter 2025 Financial Results and Provides Business Update
• Benzinga 12:55 ADT To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Friday - ADT (NYSE:ADT), Coherent (NYSE:COHR)